JPY 2425.0
(1.93%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 61.55 Billion JPY | 5.77% |
2022 | 58.19 Billion JPY | 5.53% |
2021 | 55.14 Billion JPY | -21.37% |
2020 | 70.13 Billion JPY | 8.46% |
2019 | 64.65 Billion JPY | 5.08% |
2018 | 61.53 Billion JPY | 4.84% |
2017 | 58.69 Billion JPY | 11.76% |
2016 | 52.51 Billion JPY | 1.75% |
2015 | 51.61 Billion JPY | 2.59% |
2014 | 50.31 Billion JPY | -1.45% |
2013 | 51.04 Billion JPY | 8.31% |
2012 | 47.13 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 15.18 Billion JPY | -6.17% |
2023 Q4 | 16.18 Billion JPY | -1.77% |
2023 FY | 61.55 Billion JPY | 5.77% |
2023 Q3 | 16.47 Billion JPY | 10.73% |
2023 Q2 | 14.87 Billion JPY | 6.11% |
2023 Q1 | 14.02 Billion JPY | -14.87% |
2022 FY | 58.19 Billion JPY | 5.53% |
2022 Q3 | 14.06 Billion JPY | -0.89% |
2022 Q2 | 14.19 Billion JPY | 5.34% |
2022 Q4 | 16.47 Billion JPY | 17.11% |
2022 Q1 | 13.47 Billion JPY | -7.16% |
2021 Q4 | 14.5 Billion JPY | 9.09% |
2021 Q1 | 12.88 Billion JPY | -36.67% |
2021 Q2 | 14.45 Billion JPY | 12.14% |
2021 Q3 | 13.3 Billion JPY | -7.96% |
2021 FY | 55.14 Billion JPY | -21.37% |
2020 Q4 | 20.34 Billion JPY | 17.75% |
2020 Q1 | 15.52 Billion JPY | -7.08% |
2020 Q2 | 16.97 Billion JPY | 9.3% |
2020 Q3 | 17.28 Billion JPY | 1.81% |
2020 FY | 70.13 Billion JPY | 8.46% |
2019 FY | 64.65 Billion JPY | 5.08% |
2019 Q2 | 17.11 Billion JPY | 7.08% |
2019 Q3 | 14.85 Billion JPY | -13.19% |
2019 Q4 | 16.71 Billion JPY | 12.51% |
2019 Q1 | 15.98 Billion JPY | -6.87% |
2018 Q4 | 17.15 Billion JPY | 14.5% |
2018 Q3 | 14.98 Billion JPY | -0.83% |
2018 Q2 | 15.11 Billion JPY | 5.84% |
2018 FY | 61.53 Billion JPY | 4.84% |
2018 Q1 | 14.27 Billion JPY | -16.71% |
2017 Q3 | 13.92 Billion JPY | -1.05% |
2017 Q1 | 13.55 Billion JPY | -12.05% |
2017 FY | 58.69 Billion JPY | 11.76% |
2017 Q4 | 17.14 Billion JPY | 23.1% |
2017 Q2 | 14.07 Billion JPY | 3.81% |
2016 FY | 52.51 Billion JPY | 1.75% |
2016 Q4 | 15.41 Billion JPY | 20.74% |
2016 Q2 | 12.47 Billion JPY | 5.08% |
2016 Q1 | 11.86 Billion JPY | -19.97% |
2016 Q3 | 12.76 Billion JPY | 2.36% |
2015 Q4 | 14.82 Billion JPY | 20.92% |
2015 Q1 | 11.47 Billion JPY | -24.64% |
2015 FY | 51.61 Billion JPY | 2.59% |
2015 Q2 | 13.05 Billion JPY | 13.8% |
2015 Q3 | 12.26 Billion JPY | -6.05% |
2014 Q3 | 11.85 Billion JPY | -6.35% |
2014 Q2 | 12.65 Billion JPY | 19.59% |
2014 Q1 | 10.58 Billion JPY | -27.63% |
2014 FY | 50.31 Billion JPY | -1.45% |
2014 Q4 | 15.22 Billion JPY | 28.43% |
2013 Q3 | 12.79 Billion JPY | 5.95% |
2013 Q4 | 14.62 Billion JPY | 14.25% |
2013 FY | 51.04 Billion JPY | 8.31% |
2013 Q1 | 11.54 Billion JPY | -15.86% |
2013 Q2 | 12.08 Billion JPY | 4.62% |
2012 Q2 | 11.35 Billion JPY | 0.0% |
2012 FY | 47.13 Billion JPY | 0.0% |
2012 Q3 | 11.27 Billion JPY | -0.68% |
2012 Q4 | 13.72 Billion JPY | 21.71% |
Name | Revenue | Revenue Difference |
---|---|---|
OLBA HEALTHCARE HOLDINGS, Inc. | 118.56 Billion JPY | 48.083% |
Alfresa Holdings Corporation | 2858.5 Billion JPY | 97.847% |
Vital KSK Holdings, Inc. | 587.48 Billion JPY | 89.522% |
WIN-Partners Co., Ltd. | 77.06 Billion JPY | 20.125% |
MediPal Holdings Corporation | 3558.73 Billion JPY | 98.27% |
AS ONE Corporation | 95.53 Billion JPY | 35.569% |
Suzuken Co., Ltd. | 2386.49 Billion JPY | 97.421% |